Pharmaceutical and Hospital facilities updates

[ghazi52]

Pakistan’s Maple Leaf Cement subsidiary to construct $110mn hospital in Islamabad​

BR

Novacare Hospitals (Private) Limited, a subsidiary of Maple Leaf Cement Factory Limited (MLCF), will construct a $110 million state-of-the-art hospital in Islamabad.

The development was shared by MLCF in a notice to the Pakistan Stock Exchange (PSX) on Monday.

“Novacare Hospitals (Private) Limited, a wholly-owned subsidiary of the company, will start constructing a state-of-the-art hospital in Islamabad, and has signed an international affiliation agreement with Imperial College Healthcare NHS Trust, a leading UK teaching hospital group,” read the notice.

MLCF in its notice shared that the total investment in the project will be $110 million, and the hospital will be located on a 50-Kanal plot in DHA Phase-V, Islamabad.

“The 250-bed hospital will have a covered area of 550,000 square feet and will provide comprehensive tertiary healthcare across 28 clinical services,” it added.

MLCF shared that the hospital is being designed by HKS Inc., a US-based global design firm.

“As a result of its affiliation with Imperial College Healthcare, Novacare will benefit from the expertise of a leading UK teaching hospital group. Novacare will gain expert advisory input from Imperial College Healthcare on models of care, services, and staffing, and aims to implement their clinical standards and protocols.

 

[ghazi52]

As Youm-e-Takbeer, passed few days ago let's have a look on the achievements and progress in healthcare.

– PAEC has established 19 cancer hospitals across Pakistan, providing free or subsidized treatment to 85% of patients.

– A true testament to our commitment to using nuclear energy for peaceful purposes!

 

[ghazi52]

Chinese company acquires Lahore Citi hospital, invests PKR 700 Million
By Fatima Javed | Gwadar Pro
Jun 12, 2024

LAHORE, - Jiu Zhou, a prominent Chinese company, in a joint venture with Pakistan’s TNC international, has acquired Lahore Citi Hospital. In a significant move, Jiu Zhou has invested a substantial amount of Rs. 700 million to enhance the quality of medical services provided by the hospital. The goal is to offer top-notch healthcare services to the citizens of Lahore.

Shafiq Ahmad Khan, CEO TNC International, told Gwadar pro that a joint venture has been established to advance medical development. The initial achievement of this collaboration was the establishment of GEO PAK International Hospital in Lahore, Pakistan, providing top-notch care.



He said, the Chinese company has acquired an 80% stake and intends to upgrade the hospital’s medical equipment and machinery to meet the latest standards. The hospital, which opened on June 1, 2024, boasts advanced facilities, departments, machines, and technologies to offer comprehensive assistance to patients.

Ahmad emphasized that his company is facilitating the visit of numerous Chinese enterprises to enhance investment and encourage growth in various industries, such as livestock, automotive, mining, agriculture, technology, and solar energy.



He stated that the business delegations from China have expressed a strong interest following their joint meetings with local entrepreneurs and thorough analysis of the domestic market. Their confidence and assurance in investing in Pakistan have been bolstered, and they are committed to conveying the potential of Pakistan’s rapidly expanding market to other investment firms.

Wang Yanfei, CEO Jiu Zhou, mentioned that the Henan business delegation was visiting Pakistan in March 2024. “During our trip, we explored several cities in Pakistan and carefully assessed investment opportunities. Within just two months, we finalized plans for our inaugural investment in a Lahore hospital and took it on lease for 10 years. This project marks our first venture in Pakistan, and we have ambitious plans to expand into diverse sectors. Pakistan stands out as an excellent investment destinati

 

[ghazi52]

The Attock Mother and Children Hospital and Nursing College project, undertaken by China Civil Engineering Construction Corporation (CCECC) in Pakistan completed the main building, laying a solid foundation for the completion of the project.
The project is located in Attock City of Punjab Province, eastern Pakistan. The project content includes a main hospital building, an apartment building and six supporting buildings, with a total construction area of more than 30,000 square meters.
200 beds hospital after completion, which will provide local women and children with good medical conditions and greatly improve women's health, and play an important role in public health service.

 

[ghazi52]

Two hospitals near completion in Pindi​

Construction of both hospitals ends; procurement of medical equipment underway

Correspondent
September 15, 2024

RAWALPINDI: Two major hospitals, one located near Rawat and the other at Jorian Chakri in Rawalpindi district, are nearing completion.

These hospitals, initiated during the previous government, have now reached their final stages of development, with preparations underway for their operational launch.

The Rawat Pothohar Town Tehsil Headquarters Hospital, designed to accommodate 100 beds, and the Jorian Chakri Road Hospital, with a capacity of 60 beds, together have an estimated cost exceeding Rs1.4 billion.

Construction of both hospital buildings has been completed, and the procurement process for medical equipment is underway. Final finishing touches are expected to begin next month. The foundation stone for these projects was laid by former federal minister Ghulam Sarwar Khan.

 

[ghazi52]

Under construction Hospital Lyyah, Punjab.

 

[ghazi52]

 

[ghazi52]

The Peshawar Institute of Cardiology (PIC) has reached a new milestone, becoming the first in South Asia to introduce the advanced cardiac treatment, "Super Saturated Oxygen via the TherOX Device."

This therapy has proven effective in treating heart attacks and reducing heart damage. Over three days, PIC successfully performed five procedures using this technology, treating three men and two women.

Chief Minister Ali Amin Gandapur has also directed the resumption of treatment at PIC through the Health Card facility, further expanding access to life-saving care.

 

[ghazi52]

In a major step towards strengthening social protection for residents, Chief Minister Ali Amin Gandapur has announced plans to add life insurance to the Sehat Card Plus program.

The decision came during a meeting aimed at enhancing the healthcare initiative, reflecting the government's commitment to providing more comprehensive support to its people.

 

[ghazi52]

Construction work in progress at Shaukat Khanum Cancer Hospital Karachi.

 

[ghazi52]

Nawaz Sharif Institute of Cardiology Sargodha being constructed at full speed. First of its kind in Sargodha division.

 

[ghazi52]

Manufacturing HIV drug in Pakistan: Ferozsons partners with US-based Gilead​

BR Web Desk
October 3, 2024

Ferozsons Laboratories Limited (Ferozsons), a Pakistani pharmaceutical company, has entered into a non-exclusive voluntary license agreement with Gilead Sciences Ireland UC, a US-based biopharmaceutical company, for the manufacture and sale of licensed generic lenacapavir.

The listed company shared the development in a notice to the Pakistan Stock Exchange (PSX) on Thursday.

Ferozsons informed that it is one of six global partners to have signed a voluntary license agreement with Gilead to produce high-quality generic of lenacapavir.

“Lenacapavir is approved by US FDA [Food and Drug Administration] for infection caused by the human immunodeficiency virus (HIV) for heavily treatment-experienced patients (HTE), and is being investigated for use in HIV prevention,” said the company.

The agreement covers lenacapavir for HIV prevention (pending approval), in addition to the approved indication of HIV treatment in heavily treatment-experienced (HTE) adults with multi-drug resistant HIV.

The use of lenacapavir for HIV prevention is investigational and the safety and efficacy of lenacapavir for this use have not been established, said the company.

“Under this non-exclusive license, Ferozsons or its affiliates can manufacture and sell, subject to required regulatory approvals, its licensed generic of Gilead proprietary compound Lenacapavir in 120 (one hundred twenty) primarily low and lower- middle-income countries.

“Under the licensing agreement, the company has a right to receive a technology transfer of the Gilead manufacturing process for lenacapavir to enable it to scale up production,” read the statement.

Ferozsons shared that Lenacapavir is available in two dosage forms: (a) an injectable drug product in a vial kit configuration containing 309 mg/mL Lenacapavir, or, (b) an oral tablet drug product containing 300mg of Lenacapavir.

“The injectable drug product will be manufactured at Ferozsons’ JV Subsidiary, BF Biosciences Limited (BFBIO), while the oral variant will be manufactured at Ferozsons’ oral solid dosage (OSD) facility.

 

[ghazi52]

​

Editorial: ​

Antibiotic resistance is nothing less than a medical emergency​

A coordinated strategy is needed at a national scale to reduce the microbial danger.

WHO would have thought that the medicine that was developed to cure disease would one day be overpowered by the very microorganisms it was supposed to target?

Medical science may have progressed with lightning speed over the decades, but has now hit a significant roadblock in the form of antimicrobial resistance. From Nov 18 to Nov 24 — World Antimicrobial Awareness Week — countries will be reminded of this grim reality, as thousands of people worldwide continue to die because their sickness is not responding to antibiotic treatment.


This should be especially alarming for a country like Pakistan, where the consumption of antibiotics is the third highest in the world. There are no checks on the intake of these drugs, thanks to a general lack of awareness and a lax attitude on the part of doctors, pharmacies and patients. Doctors often recommend antibiotics to patients without even diagnosing their illness; pharmacies readily sell them over the counter, and those consuming them resort to their improper use.

Under these and other circumstances, pathogens develop resistance. Indeed, when in a country like the US, with its high-quality healthcare, almost one-third of antibiotic prescriptions are not needed, one can expect worse in Pakistan, where regulations and international best practices are routinely overlooked.

The situation is nothing less than a medical emergency: between now and 2050, medical experts expect antibiotic resistance to kill 40m people worldwide. A disproportionate number is likely to be from the developing countries where healthcare is poor and disease-rife — a situation that is compounded by high levels of illiteracy and lack of education. Against this backdrop, it would indeed be a miracle if this year’s theme for WAAW — ‘Educate. Advocate. Act now’ is taken seriously by our authorities — not simply for health reasons but also to reduce the huge economic burden caused by longer hospital stays, more expensive, often inaccessible, therapy, and loss of work hours.

 

[ghazi52]

Pakistani, Chinese companies sign MoUs worth $250m to boost medical equipment trade​

APP | Dawn.com
January 18, 2025

Ambassador of Pakistan to China Khalil Hashmi witnessed signng of MoU between Pakistan and Chinese companies at China-Pakistan B2B matchmaking conference hosted by Pakistani Embassy in Beijing, on Jan 17, 2025. — PID
https://whatsapp.com/channel/0029VaMc238IiRov8okfYy3n
Pakistani and Chinese companies have signed memorandums of understanding (MoUs) worth around $250 million to boost trade in the medical and surgical sector, the Associated Press of Pakistan (APP) reported on Saturday.

Pakistan has held strong bilateral relations with China which has supported it through many investments and development projects such as the China-Pakistan Economic Corridor project which was termed as a “lifeline” for the country’s economy.

The MoUs were signed during a China-Pakistan B2B matchmaking conference on the medical equipment and surgical instrument sector held in Beijing yesterday.

APP, quoting China Economic Net (CEN), said that Silk Road Assistance Industrial Internet Platform — a provider of advisory services for companies to do cross-border businesses — signed MoUs with Pakistan’s dental and surgical instrument manufacturer Sawuat, as well as Chinese pharmaceutical company UPH Biopharma.

According to CEN, the collaboration aims to encourage more Chinese companies to set up joint ventures in the medical instrument sector.

Pakistan’s embassy in Beijing also confirmed in a statement yesterday that three MoUs worth $250m were signed during the conference.

The embassy said it hosted, in collaboration with the Board of Investment (BOI), the sixth moot in a series of sector-specific B2B matchmaking meetings focused on investment partnerships between Pakistan and China in the medical sector.

“Over 80 Chinese companies and associations and more than 20 Pakistani companies participated both in person and online,” it noted.

On the occasion, Pakistan’s ambassador to China Khalil Hashmi highlighted the growing potential of the medical industry in Pakistan, saying it was valued at over $600m.

The embassy said Hashmi announced Pakistan would host the 4th Health, Engineering, and Minerals Show (HEMS) in Lahore from April 17-19, 2025, with a special focus on surgical and medical instruments.

 

[ghazi52]

Under Construction Nawaz Sharif Cancer Hospital Lahore. Where level-three & level-four patients will also be treated free of charge.

- 3 Pediatric Oncology
- Operation Theaters
- 10 Radiation Therapy Bunkers
- ICU
- 30 Bed Emergency Ward
- Bone Marrow Centre
- Cancer Care Clinics

The first phase of the Hospital to be Completed by October 2025